Private Equity: Buyouts & Venture Capital Investment (International Firms) - China
Band 5
What the Team is Known For
The well-reputed private equity team at O'Melveny & Myers is mandated by corporates on venture capital, buyouts and other private equity deals. It is equally skilled in representing Chinese and international private equity houses, as well as sovereign wealth funds, leveraging significant US-based expertise. The firm boasts impressive real estate deal expertise and is active on deals in the e-commerce sector as well as those in the areas of hospitality, real estate and technology.
Strengths
The firm has a deep understanding of investment structures within China.
Work Highlights
O'Melveny & Myers acted for Tianhui Biotech in a series of agreements with Oramed Pharmaceuticals regarding the establishment of a new joint venture, OraTech Pharmaceuticals.
Notable practitioners
Nima Amini is managing partner of O'Melveny's Hong Kong office, and is recognised for his work for corporate clients and sovereign wealth funds on investment, financing and acquisition deals. He handles transactions for clients in a wide range of sectors including the technology and e-commerce industries.
Nima delivers an excellent service that is highly pragmatic and very commercially and legally dynamic.
